Latest Hepatocyte Stories
YOKOHAMA, Japan, January 4, 2011 /PRNewswire/ -- ReproCELL, Inc.
The liver's unique ability among organs to regenerate itself has been little understood.
CHARLOTTESVILLE, Va., Oct. 12 /PRNewswire/ -- Beta-Pro LLC, announced today that it has expanded its operations to accommodate increasing demands from pharmaceutical drug discovery and research institutes in the $2 billion hepatocyte market.
CHICAGO, Sept. 10 /PRNewswire/ -- Celsis In Vitro, Inc.
Discarded livers have potential to be reengineered into usable replacement organs.
A research team from the National Taiwan University Hospital has evaluated the efficiency of transplanted hepatocyte (liver) cells in animal models severely damaged by two kinds of chemical toxicity to see whether and how transplanted hepatocytes were able to efficiently repopulate the toxin-induced, severely damaged livers.
Embryonic stem (ES) cells, known for their capacity to proliferate indefinitely and differentiate into almost all types of cells including hepatocytes, have raised the hope of cellular replacement therapy for liver failure.
Scientists have for the first time produced liver cells from adult skin cells using the induced pluripotent stem cell (iPSC) technology.
CHIBA, Japan, Oct.
A combination of bioengineering and medical research at the University of California, San Diego has led to a new discovery that could pave the way for more effective treatments for liver disease.